166 related articles for article (PubMed ID: 195983)
1. Metabolic effects of diphosphonate in primary hyperparathyroidism.
Kaplan RA; Geho WB; Poindexter C; Haussler M; Dietz GW; Pak CY
J Clin Pharmacol; 1977 Jul; 17(7):410-9. PubMed ID: 195983
[TBL] [Abstract][Full Text] [Related]
2. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
Reasner CA; Stone MD; Hosking DJ; Ballah A; Mundy GR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1067-71. PubMed ID: 8408454
[TBL] [Abstract][Full Text] [Related]
3. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
Shane E; Baquiran DC; Bilezikian JP
Ann Intern Med; 1981 Jul; 95(1):23-7. PubMed ID: 6264825
[TBL] [Abstract][Full Text] [Related]
4. Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the ultrastructure of parathyroid glands and plasma immunoreactive parathyroid hormone in pregnant cows fed a low calcium diet.
Yarrington JT; Capen CC; Black HE; Re R; Potts JT; Geho WB
Lab Invest; 1977 Apr; 36(4):402-12. PubMed ID: 191694
[TBL] [Abstract][Full Text] [Related]
5. Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resportion.
Yarrington JT; Capen CC; Black HE; Re R; Potts JT; Geho WB
Am J Pathol; 1976 Jun; 83(3):569-88. PubMed ID: 180813
[TBL] [Abstract][Full Text] [Related]
6. An apparent 1,25-dihydroxyvitamin D-independent stimulation of intestinal calcium absorption in patients with Paget disease of bone during a short-term diphosphonate therapy.
Norman DA; Zerwekh JE; Pak CY
Metabolism; 1981 Mar; 30(3):290-2. PubMed ID: 6782425
[TBL] [Abstract][Full Text] [Related]
7. Effect of diphosphonates on adenosine 3':5'-cyclic monophosphate in mouse calvaria after stimulation by parathyroid hormone in vitro.
Gebauer U; Russell RG; Touabi M; Fleisch H
Clin Sci Mol Med; 1976 Jun; 50(6):473-8. PubMed ID: 179750
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
9. Effect of phenytoin on bone and vitamin D metabolism.
Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M
Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
[TBL] [Abstract][Full Text] [Related]
10. Treatment of calcium urolithiasis with diphosphonate: efficacy and hazards.
Bone HG; Zerwekh JE; Britton F; Pak CY
J Urol; 1979 May; 121(5):568-71. PubMed ID: 220433
[TBL] [Abstract][Full Text] [Related]
11. Treatment of postmenopausal hyperparathyroidism with norethindrone. Effects on biochemistry and forearm mineral density.
Horowitz M; Wishart J; Need AG; Morris H; Philcox J; Nordin BE
Arch Intern Med; 1987 Apr; 147(4):681-5. PubMed ID: 3827457
[TBL] [Abstract][Full Text] [Related]
12. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
Pak CY; Oata M; Lawrence EC; Snyder W
J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
[TBL] [Abstract][Full Text] [Related]
13. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of calcium metabolism in children with vitamin D-deficiency rickets.
Kruse K
J Pediatr; 1995 May; 126(5 Pt 1):736-41. PubMed ID: 7751997
[TBL] [Abstract][Full Text] [Related]
15. Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Ishimura E; Miki T; Koyama H; Harada K; Nakatsuka K; Inaba M; Nishizawa Y; Morii H
Horm Metab Res; 1993 Sep; 25(9):493-7. PubMed ID: 8225204
[TBL] [Abstract][Full Text] [Related]
16. A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy.
Horiuchi T; Onouchi T; Inoue J; Shionoiri A; Hosoi T; Orimo H
Gerontology; 2002; 48(2):103-8. PubMed ID: 11867933
[TBL] [Abstract][Full Text] [Related]
17. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
Connors MH; Irias JJ; Golabi M
Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
20. Nonautonomy of parathyroid hormone and urinary cyclic AMP in primary hyperparathyroidism.
Monchik JM; Wray HL; Schaaf M; Earll JM
Am J Surg; 1977 Apr; 133(4):498-505. PubMed ID: 192097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
